Skip to main content
. 2024 Nov 29;14:1478672. doi: 10.3389/fonc.2024.1478672

Figure 6.

Figure 6

Differences of clinical features in high and low PRMT5 groups. (A–E) The expression difference in tumor stage (T, N, and M), sex, and age between the two groups. (F, G) GSEA results of DEGs between two PRMT5 groups.